The offer includes a reservation of up to 108,900 equity shares of face value of ₹10 each for subscription by eligible employees
Emcure Pharmaceuticals Limited proposes to open its initial public offering of Equity Shares on Wednesday, July 03, 2024. The Anchor Investor Bid/Offer Period is one Working Day before the Bid/Offer Opening Date, Tuesday, July 02, 2024. The bid Offer Closing Date will be Friday, July 05, 2024.
The Price Band of the Offer has been fixed from ₹ 960 per Equity Share to ₹ 1008 per Equity Share. Bids can be made for at least 14 Equity Shares and multiples of 14 Equity Shares afterwards.
The initial public offering of up to equity shares of the face value of Rs 10 each of Emcure Pharmaceuticals Limited comprising a fresh issue of up to equity shares of the face value of Rs 10 each aggregating up to Rs 8,000 million by the Company (the “Fresh Issue”) and an offer for sale of up to 11,428,839 equity shares of the face value of Rs10 each. 420,000 equity shares of face value of Rs 10 each aggregating by Satish Ramanlal Mehta, up to 1,268,600 equity shares of face value of Rs 10 each by Namita Vikas Thapar, up to 10,000 equity shares of face value of Rs 10 each by Samit Satish Mehta and up to 40,000 equity shares of face value of Rs 10 each by Sunil Rajanikant Mehta (the “Promoter Selling Shareholders”), up to 7,234,085 equity shares of face value of Rs 10 each by BC Investments IV Limited (the “Investor Selling Shareholder”), up to 1,342,586 equity shares of face value of Rs 10 each by the promoter group selling shareholders as set out under Annexure A of the RHP (the “Promoter Group Selling Shareholders”), up to 300,000 equity shares of face value of Rs 10 each by Arunkumar Purshotamlal Khanna (the “Individual Selling Shareholder”), and up to 813,568 equity shares of face value of Rs 10 each by other selling shareholders as set out under Annexure of the RHP (the “Other Selling Shareholders”, and collectively with the Promoter Selling Shareholders, Promoter Group Selling Shareholders, Individual Selling Shareholder and the Investor Selling Shareholder, the “Selling Shareholders”, and each individually, as a “Selling Shareholder” and such offer for sale of equity shares of face value of ₹10 each by the Selling Shareholders, the “Offer for Sale”).
The offer includes a reservation of up to 108,900 equity shares of face value of ₹10 each for subscription by eligible employees (the “Employee Reservation Portion”). The Company, in consultation with the Book Running Lead Managers, has offered a discount of up to ₹90 per Equity Share to Eligible Employees bidding under the Employee Reservation Portion (“Employee Discount”). The Offer less the Employee Reservation Portion is hereinafter referred to as the “Net Offer”.
The Company proposes to utilize the net proceeds towards repayment and prepayment of all or a portion of certain outstanding borrowings availed by the Company and general corporate purposes.